Insider · CIK 0001786484

Burrell Terry-Ann

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001786484

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-07-01	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+1,843 sh	—	—	71,254
2024-06-03	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+26.2K sh	—	—	26,193
2024-06-03	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+13.1K sh	—	—	69,411
2024-04-26	BEAMBeam Therapeutics Inc.A Award	Chief Financial Officer	AAward	+12.5K sh	—	—	82,637
2024-04-26	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+25K sh	—	—	25,000
2024-04-01	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+1,467 sh	—	—	56,314
2024-04-01	BEAMBeam Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−5,446 sh	$32.12	−$175K	70,137
2024-03-31	BEAMBeam Therapeutics Inc.A Award	Chief Financial Officer	AAward	+27.5K sh	—	—	75,583
2024-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+55K sh	$24.40	+$1.34M	55,000
2023-07-13	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−8,275 sh	$12.59	−$104K	54,847
2023-07-12	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,157 sh	$14.08	−$44.5K	63,122
2023-07-12	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,195 sh	$13.18	−$42.1K	66,279
2023-07-12	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−78.1K sh	$12.15	−$948K	69,474
2023-07-12	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−24.3K sh	$11.25	−$273K	147,545
2023-06-16	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+12.6K sh	—	—	171,847
2023-06-16	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+25.2K sh	—	—	25,224
2023-04-04	BEAMBeam Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−2,186 sh	$29.09	−$63.6K	47,117
2023-04-03	BEAMBeam Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−2,454 sh	$30.31	−$74.4K	49,303
2023-03-31	BEAMBeam Therapeutics Inc.A Award	Chief Financial Officer	AAward	+20K sh	—	—	51,277
2023-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+20K sh	—	—	20,000
2023-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2023-01-27	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+36.2K sh	$13.68	+$495K	67,429
2023-01-27	BEAMBeam Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−36.2K sh	$45.08	−$1.63M	31,277
2023-01-27	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−36.2K sh	—	—	185,565
2023-01-26	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,102 sh	—	—	221,717
2023-01-26	BEAMBeam Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−1,102 sh	$45.16	−$49.8K	31,277
2023-01-26	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,102 sh	$13.68	+$15.1K	32,379
2023-01-24	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+14.8K sh	$13.68	+$203K	46,087
2023-01-24	BEAMBeam Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−14.8K sh	$45.01	−$667K	31,277
2023-01-24	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−14.8K sh	—	—	222,819
2023-01-23	BEAMBeam Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−5,426 sh	$45.02	−$244K	31,277
2023-01-23	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,426 sh	$13.68	+$74.2K	36,703
2023-01-23	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,426 sh	—	—	237,629
2023-01-18	BEAMBeam Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−47.2K sh	$45.14	−$2.13M	31,277
2023-01-18	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−39.9K sh	—	—	243,055
2023-01-18	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+39.9K sh	$13.68	+$546K	78,472
2023-01-03	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+1,821 sh	—	—	159,235
2022-10-03	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+1,265 sh	—	—	157,414
2022-07-01	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+1,631 sh	—	—	156,149
2022-06-14	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+18.1K sh	—	—	154,518
2022-06-14	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+36.3K sh	—	—	36,290
2022-04-01	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+1,788 sh	—	—	136,373
2022-03-31	BEAMBeam Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−1,787 sh	$59.11	−$106K	38,278
2022-03-31	BEAMBeam Therapeutics Inc.A Award	Chief Financial Officer	AAward	+15K sh	—	—	40,065
2022-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+30K sh	—	—	30,000
2022-01-03	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+763 sh	—	—	134,585
2021-10-01	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+629 sh	—	—	133,822
2021-07-01	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+382 sh	—	—	133,193
2021-06-30	BEAMBeam Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−15K sh	$117.00	−$1.76M	39,809
2021-06-30	BEAMBeam Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−15K sh	$127.00	−$1.91M	24,809

Recent filings

Accepted (ET)
Jul 34
Burrell Terry-Ann0001601830-24-000097
SEC(opens sec.gov)
Jun 54
Burrell Terry-Ann0001601830-24-000073
SEC(opens sec.gov)
Apr 294
Burrell Terry-Ann0000950170-24-049854
SEC(opens sec.gov)
Apr 34
Burrell Terry-Ann0000950170-24-041437
SEC(opens sec.gov)
Apr 34
Burrell Terry-Ann0001601830-24-000028
SEC(opens sec.gov)
Apr 24
Burrell Terry-Ann0000950170-24-040154
SEC(opens sec.gov)
Feb 24
Burrell Terry-Ann0000950170-24-010480
SEC(opens sec.gov)
Jul 144
Burrell Terry-Ann0001209191-23-042305
SEC(opens sec.gov)
Jun 214
Burrell Terry-Ann0001209191-23-038838
SEC(opens sec.gov)
Apr 194/A
Burrell Terry-Ann0000950170-23-013483
SEC(opens sec.gov)
Apr 54
Burrell Terry-Ann0000899243-23-010815
SEC(opens sec.gov)
Mar 314
Burrell Terry-Ann0000899243-23-010132
SEC(opens sec.gov)

Companies

Address

C/O BEAM THERAPEUTICS INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139